Ballendine Stephanie A, Greba Quentin, Dawicki Wojciech, Zhang Xiaobei, Gordon John R, Howland John G
Dept. of Physiology, University of Saskatchewan, GB33, Health Sciences Building, 107 Wiggins Rd, Saskatoon, SK S7N5E5, Canada.
Dept. of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
Prog Neuropsychopharmacol Biol Psychiatry. 2015 Mar 3;57:155-65. doi: 10.1016/j.pnpbp.2014.11.002. Epub 2014 Nov 12.
Research suggests that maternal immune activation (MIA) during pregnancy increases the risk of neurodevelopmental disorders including schizophrenia and autism in the offspring. Current theories suggest that inflammatory mediators including cytokines and chemokines may underlie the increased risk of these disorders in humans. For example, elevated maternal interleukin-8 (IL-8) during pregnancy is associated with increased risk of schizophrenia in the offspring. Given this association, the present experiments examined ELR-CXC chemokines CXCL1 and CXCL2, rodent homologues of human IL-8, and activation of their receptors (CXCR1 and CXCR2) in an established rodent model of MIA. Pregnant Long Evans rats were treated with the viral mimetic polyinosinic-polycytidylic acid (polyI:C; 4 mg/kg, i.v.) on gestational day 15. Protein analysis using multiplex assays and ELISA showed that polyI:C significantly increased maternal serum concentrations of interleukin-1β, tumor necrosis factor, and CXCL1 3h after administration. Subsequent experiments tested the role of elevated maternal CXCL1 on behavior of the offspring by administering a CXCR1/CXCR2 antagonist (G31P; 500 μg/kg, i.p.; 1h before, 48 and 96 h after polyI:C treatment). The male offspring of dams treated with polyI:C demonstrated subtle impairments in prepulse inhibition (PPI), impaired associative and crossmodal recognition memory, and altered behavioral flexibility in an operant test battery. While G31P did not completely reverse the behavioral impairments caused by polyI:C, it enhanced PPI during adolescence and strategy set-shifting and reversal learning during young adulthood. These results suggest that while polyI:C treatment significantly increases maternal CXCL1, elevations of this chemokine are not solely responsible for the effects of polyI:C on the behavior of the offspring.
研究表明,孕期母体免疫激活(MIA)会增加后代患包括精神分裂症和自闭症在内的神经发育障碍的风险。目前的理论认为,包括细胞因子和趋化因子在内的炎症介质可能是人类患这些疾病风险增加的原因。例如,孕期母体白细胞介素-8(IL-8)水平升高与后代患精神分裂症的风险增加有关。鉴于这种关联,本实验在已建立的MIA啮齿动物模型中研究了ELR-CXC趋化因子CXCL1和CXCL2(人类IL-8的啮齿动物同源物)及其受体(CXCR1和CXCR2)的激活情况。在妊娠第15天,给怀孕的长 Evans 大鼠静脉注射病毒模拟物聚肌苷酸-聚胞苷酸(polyI:C;4mg/kg)。使用多重检测和酶联免疫吸附测定(ELISA)进行的蛋白质分析表明,polyI:C给药后3小时显著增加了母体血清中白细胞介素-1β、肿瘤坏死因子和CXCL1的浓度。随后的实验通过给予CXCR1/CXCR2拮抗剂(G31P;500μg/kg,腹腔注射;在polyI:C治疗前1小时、治疗后48小时和96小时)来测试母体CXCL1升高对后代行为的作用。用polyI:C处理的母鼠的雄性后代在预脉冲抑制(PPI)方面表现出细微损伤,联想和跨模态识别记忆受损,并且在操作性测试组中行为灵活性改变。虽然G31P没有完全逆转polyI:C引起的行为损伤,但它增强了青春期的PPI以及成年早期的策略转换和逆向学习。这些结果表明,虽然polyI:C治疗显著增加了母体CXCL1,但这种趋化因子的升高并非polyI:C对后代行为产生影响的唯一原因。